Skip to main content
. 2022 Feb 2;119(6):e2118895119. doi: 10.1073/pnas.2118895119

Table 3.

Univariate analysis for predictors of antibody response at 21 d and 6 mo of follow-up for rVSVΔG-ZEBOV-GP vaccine recipients in Beni, DRC

21 d (n = 548) 6 mo (n = 434)
Antibody titer ratio 95% CI Antibody titer ratio 95% CI
Sex
 Male Reference Reference
 Female 1.11 0.93, 1.32 1.35 1.15, 1.58
Age, y
 12–19 Reference Reference
 20–29 0.72 0.54, 0.96 0.67 0.51, 0.90
 30–39 0.65 0.49, 0.87 0.65 0.49, 0.86
 40–49 0.56 0.41, 0.75 0.75 0.56, 1.01
 50–82 0.66 0.47, 0.93 0.84 0.61, 1.17
Education*
 None 0.66 0.43, 1.03 0.77 0.52, 1.14
 Any primary school or apprenticeship Reference Reference
 Finished secondary school 1.05 0.83, 1.31 0.89 0.74, 1.07
 College/university or graduate school 0.87 0.71, 1.06 0.96 0.81, 1.14
Marital status
 Single 1.22 1.03, 1.46 1.07 0.93, 1.25
 Married or living together as married Reference Reference
 Divorced, separated, or widowed 1.13 0.63, 2.05 1.25 0.77, 2.03
Currently a health care worker?
 Yes 0.83 0.70, 0.99 0.98 0.85, 1.14
 No Reference Reference
Has ever had contact with a confirmed, probable, or suspected EVD case?
 Yes 0.87 0.72, 1.05 0.96 0.81, 1.14
 No Reference Reference
 Don’t know 0.91 0.66, 1.27 1.05 0.81, 1.36

*One missing response.

Four missing responses.

61 missing responses.